IAMOG
DMK

Investors Asset Management of Georgia’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Investors Asset Management of Georgia’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1
Closed – – 555
2022
Q3 		$0 Hold
1
– – ﹤0.01% 666
2022
Q2 		$0 Buy
+1
New +$31 ﹤0.01% 604

Other funds holding DMK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $7.59B AUM 23.44% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Investors Asset Management of Georgia's DMK Position: Q4 2022 in Review

Investors Asset Management of Georgia sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q4 2022, closing a stake of 1 share.

Investors Asset Management of Georgia first reported a position in DMK in Q2 2022 and held it in 2 quarters. The position peaked at $0 in Q3 2022. 48 funds tracked by Wall St. Rank hold DMK as of Q4 2022.

  • Investors Asset Management of Georgia reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q4 2022 after selling out during the quarter.
  • Investors Asset Management of Georgia sold 1 DMK Pharmaceuticals Corporation Common Stock share in Q4 2022.
  • Investors Asset Management of Georgia first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q2 2022 and held it in 2 quarters.
  • Investors Asset Management of Georgia's DMK Pharmaceuticals Corporation Common Stock position peaked at $0 in Q3 2022.
  • 48 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q4 2022.

Based on Investors Asset Management of Georgia's 13F filing for Q4 2022, filed 2 Feb 2023.